For biopharmaceutical companies, gene therapies are an economic challenge. They are expensive to make yet the diseases the treat are rare, so manufacturers tend to charge a lot for them to generate ...

Tucson-based small-satellite launch startup Vector has won a key U.S. patent for its small-rocket engine technology as it moves toward its first orbital flight later this year. Vector was awarded ...

The lentiviral vector market is rapidly growing, driven by advancements in gene therapy and increasing demand for innovative medical treatments. In 2023, the market was valued at USD 176.8 million and ...

Zhejiang Provincial Key Laboratory of Vector Biology and Pathogen Control, Huzhou University has the following research output in the current window (1 September 2024 - 31 August 2025) of the Nature ...